anemodeanin a has been researched along with beta-escin in 22 studies
| Studies (anemodeanin a) | Trials (anemodeanin a) | Recent Studies (post-2010) (anemodeanin a) | Studies (beta-escin) | Trials (beta-escin) | Recent Studies (post-2010) (beta-escin) |
|---|---|---|---|---|---|
| 29 | 0 | 27 | 14,137 | 211 | 6,278 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 14 (63.64) | 24.3611 |
| 2020's | 8 (36.36) | 2.80 |
| Authors | Studies |
|---|---|
| Sun, W; Wang, RP; Wu, J; Xu, JL; Xue, G; Zhou, JY; Zou, X | 1 |
| Chen, QL; Guan, JL; Qian, S; Wang, ZY; Wu, Y | 1 |
| Chen, HZ; Fang, C; Gao, YG; Guan, YY; Liu, HJ; Liu, YR; Lu, Q; Luan, X; Xu, JR; Zhao, M | 1 |
| Cai, GZ; Gong, JY; Li, JN; Li, ZM; Yu, Y; Zhang, YF | 1 |
| Peng, Z; Wu, C; Zhang, C; Zhang, Y; Zhou, W | 1 |
| Cheng, Y; Guan, YD; Jiang, SL; Wen, M; Xiao, SS; Xu, XJ; Yu, P; Zhang, Y | 1 |
| Chen, S; Fan, S; Feng, M; He, W; Huang, K; Ma, J; Mo, J; Wang, J; Wang, Q; Xie, Z; Zhao, C | 1 |
| Hou, X; Liu, Y; Ouyang, Z; Peng, F; Shen, C; Shu, M; Wang, L; Wang, X; Yang, M; Zhang, LW; Zhao, B; Zhao, S | 1 |
| Ma, B; Wang, Y; Zhang, H; Zhang, J; Zhang, L; Zhang, Q; Zhao, A; Zhu, J | 1 |
| Bao, X; Ma, B; Wang, Y; Zhang, J; Zhang, M; Zhang, Q; Zhao, A | 1 |
| Cai, Z; Hua, Y; Mao, M; Sun, W; Wang, C; Wang, G; Wang, H; Wang, Z; Xu, J; Yin, F; Zhang, T; Zhou, Z; Zuo, D | 1 |
| Bai, S; Dong, Y; Hu, C; Lyu, J; Xia, H; Yu, X; Zhan, Y; Zhang, BY; Zhao, L | 1 |
| Cai, Z; Hua, Y; Mao, M; Shen, J; Sun, W; Wang, G; Wang, H; Wang, Z; Xu, J; Yin, F; Zhang, T; Zhou, Z; Zuo, D | 1 |
| Fan, QX; Guo, SS; Wang, Y | 1 |
| Ahn, KS; Khan, MR; Naz, I; Ramchandani, S; Yang, MH | 1 |
| Jin, W; Lu, S; Shi, H; Shu, Y; Wang, X | 1 |
| He, Y; Li, L; Lv, X; Ma, J; Shen, X | 1 |
| Cheng, H; Dai, X; Wang, B; Wang, W; Wu, B; Ye, L; Zhu, J | 1 |
| Cai, GZ; Gong, JY; Jiang, CF; Li, JN; Liu, X; Wang, YY | 1 |
| Cai, R; Chen, M; Li, G; Li, L | 1 |
| Cao, XW; Kang, JY; Wang, FJ; Zhao, J | 1 |
| Hei, B; Liu, RE; Miao, Z; Ouyang, J; Wang, D; Zhou, J | 1 |
1 review(s) available for anemodeanin a and beta-escin
| Article | Year |
|---|---|
Anticancer Potential of Raddeanin A, a Natural Triterpenoid Isolated from
Topics: Anemone; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Humans; Saponins; Triterpenes; Wnt Signaling Pathway | 2020 |
21 other study(ies) available for anemodeanin a and beta-escin
| Article | Year |
|---|---|
Raddeanin A induces human gastric cancer cells apoptosis and inhibits their invasion in vitro.
Topics: Anemone; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Proliferation; Gastric Mucosa; Gene Expression Regulation, Neoplastic; Humans; Neoplasm Invasiveness; RNA, Messenger; Saponins; Stomach; Stomach Neoplasms | 2013 |
Synthesis and biological evaluation of Raddeanin A, a triterpene saponin isolated from Anemone raddeana.
Topics: Anemone; Antineoplastic Agents; HeLa Cells; Histone Deacetylase Inhibitors; Humans; Saponins | 2014 |
Raddeanin A, a triterpenoid saponin isolated from Anemone raddeana, suppresses the angiogenesis and growth of human colorectal tumor by inhibiting VEGFR2 signaling.
Topics: Anemone; Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Chick Embryo; Colorectal Neoplasms; Female; Human Umbilical Vein Endothelial Cells; Humans; Mice; Mice, Inbred BALB C; Molecular Docking Simulation; Neovascularization, Pathologic; Saponins; Signal Transduction; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays; Zebrafish | 2015 |
Synergy of Raddeanin A and cisplatin induced therapeutic effect enhancement in human hepatocellular carcinoma.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cisplatin; Drug Synergism; Gene Expression Regulation, Neoplastic; Humans; Liver; Liver Neoplasms; Reactive Oxygen Species; Saponins | 2017 |
The STAT3/NFIL3 signaling axis-mediated chemotherapy resistance is reversed by Raddeanin A via inducing apoptosis in choriocarcinoma cells.
Topics: Apoptosis; Basic-Leucine Zipper Transcription Factors; Cell Line, Tumor; Cell Survival; Choriocarcinoma; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Saponins; Signal Transduction; STAT3 Transcription Factor | 2018 |
Suppression of eEF-2K-mediated autophagy enhances the cytotoxicity of raddeanin A against human breast cancer cells in vitro.
Topics: Antineoplastic Agents; Apoptosis; Autophagy; Breast Neoplasms; Cell Line, Tumor; Chloroquine; Down-Regulation; Elongation Factor 2 Kinase; Female; Heterocyclic Compounds, 3-Ring; Humans; Proto-Oncogene Proteins c-akt; Saponins; Signal Transduction; TOR Serine-Threonine Kinases | 2018 |
Raddeanin A suppresses breast cancer-associated osteolysis through inhibiting osteoclasts and breast cancer cells.
Topics: Animals; Blotting, Western; Bone Resorption; Breast Neoplasms; Cell Survival; Female; Humans; In Situ Nick-End Labeling; Mice; Mice, Inbred C57BL; Osteoclasts; Osteolysis; Saponins | 2018 |
Raddeanin a Suppresses Glioblastoma Growth by Inducing ROS Generation and Subsequent JNK Activation to Promote Cell Apoptosis.
Topics: Apoptosis; Cell Line, Tumor; Enzyme Activation; Glioblastoma; Humans; MAP Kinase Kinase 4; Neoplasm Proteins; Reactive Oxygen Species; Saponins | 2018 |
Raddeanin A, a natural triterpenoid saponin compound, exerts anticancer effect on human osteosarcoma via the ROS/JNK and NF-κB signal pathway.
Topics: Anemone; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Drug Screening Assays, Antitumor; Humans; MAP Kinase Signaling System; Membrane Potential, Mitochondrial; Mice; Mice, Inbred BALB C; Neoplasm Invasiveness; NF-kappa B; Osteosarcoma; Reactive Oxygen Species; Saponins; Signal Transduction; Xenograft Model Antitumor Assays | 2018 |
Raddeanin A inhibits growth and induces apoptosis in human colorectal cancer through downregulating the Wnt/β-catenin and NF-κB signaling pathway.
Topics: Animals; Antineoplastic Agents; Apoptosis; beta Catenin; Caco-2 Cells; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Down-Regulation; Humans; Male; Membrane Potential, Mitochondrial; Mice; Mice, Nude; Mitochondria; Neoplasm Transplantation; NF-kappa B p50 Subunit; Phosphorylation; RNA, Small Interfering; Saponins; Triterpenes; Wnt Proteins; Wnt Signaling Pathway; Xenograft Model Antitumor Assays | 2018 |
Attenuation of STAT3 Phosphorylation Promotes Apoptosis and Chemosensitivity in Human Osteosarcoma Induced by Raddeanin A.
Topics: Animals; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cell Survival; Female; Flow Cytometry; Humans; In Situ Nick-End Labeling; Interleukin-6; Mice; Mice, Inbred BALB C; Osteosarcoma; Phosphorylation; Reverse Transcriptase Polymerase Chain Reaction; Saponins; STAT3 Transcription Factor | 2019 |
Raddeanin A down-regulates androgen receptor and its splice variants in prostate cancer.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Docetaxel; Down-Regulation; Drug Synergism; Gene Expression Regulation, Neoplastic; Humans; Male; PC-3 Cells; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Protein Isoforms; Receptors, Androgen; RNA Splicing; Saponins | 2019 |
Antitumor activity of Raddeanin A is mediated by Jun amino-terminal kinase activation and signal transducer and activator of transcription 3 inhibition in human osteosarcoma.
Topics: Animals; Antineoplastic Agents, Phytogenic; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Humans; Male; MAP Kinase Signaling System; Mice; Osteosarcoma; Reactive Oxygen Species; Saponins; STAT3 Transcription Factor; Time Factors; Xenograft Model Antitumor Assays | 2019 |
Raddeanin A promotes apoptosis and ameliorates 5-fluorouracil resistance in cholangiocarcinoma cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Bile Duct Neoplasms; Cell Line, Tumor; Cell Movement; Cell Survival; Cholangiocarcinoma; Drug Resistance, Neoplasm; Fluorouracil; Humans; Saponins | 2019 |
Raddeanin A suppresses lung cancer cell proliferation via induction of apoptosis and increased production of ROS.
Topics: Acetylcysteine; Apoptosis; bcl-2-Associated X Protein; Biomarkers, Tumor; Cell Line, Tumor; Cell Proliferation; Cytochromes c; Humans; Lung Neoplasms; Membrane Potential, Mitochondrial; Reactive Oxygen Species; Saponins | 2020 |
Raddeanin A inhibits proliferation, invasion, migration and promotes apoptosis of cervical cancer cells via regulating miR-224-3p/Slit2/Robo1 signaling pathway.
Topics: Antineoplastic Agents; Apoptosis; Cell Movement; Cell Proliferation; Female; Humans; Intercellular Signaling Peptides and Proteins; MicroRNAs; Neoplasm Invasiveness; Nerve Tissue Proteins; Receptors, Immunologic; Roundabout Proteins; Saponins; Signal Transduction; Tumor Cells, Cultured; Up-Regulation; Uterine Cervical Neoplasms | 2021 |
Raddeanin A inhibited epithelial-mesenchymal transition (EMT) and angiogenesis in glioblastoma by downregulating β-catenin expression.
Topics: Animals; beta Catenin; Brain Neoplasms; Cell Proliferation; Down-Regulation; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Glioblastoma; Human Umbilical Vein Endothelial Cells; Humans; Mice; Neovascularization, Pathologic; Saponins; Vascular Endothelial Growth Factor A; Wnt Signaling Pathway; Xenograft Model Antitumor Assays | 2021 |
The study of Raddeanin A cerebrovascular endothelial cell trafficking through P-glycoprotein.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Brain; Drug Resistance; Endothelial Cells; Humans; Intracellular Space; Microvessels; Saponins | 2021 |
Raddeanin A induced apoptosis of non-small cell lung cancer cells by promoting ROS-mediated STAT3 inactivation.
Topics: A549 Cells; Apoptosis; Carcinoma, Non-Small-Cell Lung; Humans; Lung Neoplasms; Neoplasm Proteins; Reactive Oxygen Species; Saponins; STAT3 Transcription Factor | 2021 |
Raddeanin A synergistically enhances the anti-tumor effect of MAP30 in multiple ways, more than promoting endosomal escape.
Topics: Endosomes; Humans; Neoplasms; Ribosome Inactivating Proteins, Type 2; Saponins; Triterpenes | 2022 |
Raddeanin A (RA) reduced acute inflammatory injury in mouse experimental cerebral hemorrhage by suppression of TLR4.
Topics: Animals; Brain Edema; Cerebral Hemorrhage; Mice; Microglia; Saponins; Toll-Like Receptor 4 | 2022 |